United States Biotechnology & Medical Research

Genomic Health Inc (GHDX)

Track

Track

Ticker: GHDX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
EXACT SCIENCES CORP See Footnotes Large shareholder
Transaction date
Purchase
Price
201.04
Quantity 38,057
Value US$1,334,501
Leber Laura Chief Communication Officer
Transaction date
Planned sale
Price
464.43
Quantity 77,934 +27.2%
Value US$3,832,758
Vaughn James J Chief Commercial Officer
Transaction date
Planned sale
Price
89.05
Quantity 51,285 -28.3%
Value US$4,901,790
Popovits Kimberly J President and CEO Executive Director
Transaction date
Planned sale
Price
67.74
Quantity 10,000 -12.8%
Value US$677,364
3.2
Cole G Bradley CFO
Transaction date
Planned sale
Price
69.01
Quantity 22,560 -36.7%
Value US$1,556,886
Shak Steven Chief Scientific Officer
Transaction date
Planned sale
Price
71.47
Quantity 25,000 -29.8%
Value US$1,786,692
3.2
Cole G Bradley CFO
Transaction date
Planned sale
Price
72.33
Quantity 4,809 -11.0%
Value US$347,848
3.2
Cole G Bradley CFO
Transaction date
Planned sale
Price
71.60
Quantity 13,303 -23.3%
Value US$952,428
Vaughn James J Chief Commercial Officer
Transaction date
Planned sale
Price
74.13
Quantity 200 -1.2%
Value US$14,826
Vaughn James J Chief Commercial Officer
Transaction date
Planned sale
Price
73.24
Quantity 1,300 -7.3%
Value US$95,213
Vaughn James J Chief Commercial Officer
Transaction date
Planned sale
Price
72.08
Quantity 3,000 -14.3%
Value US$216,230
Popovits Kimberly J President and CEO Executive Director
Transaction date
Planned sale
Price
74.10
Quantity 600 -0.8%
Value US$44,460
Popovits Kimberly J President and CEO Executive Director
Transaction date
Planned sale
Price
73.35
Quantity 2,483 -3.1%
Value US$182,125
Popovits Kimberly J President and CEO Executive Director
Transaction date
Planned sale
Price
72.10
Quantity 6,917 -7.8%
Value US$498,700
3.2
Cole G Bradley CFO
Transaction date
Planned sale
Price
74.00
Quantity 1,762 -4.3%
Value US$130,392
3.2
Cole G Bradley CFO
Transaction date
Planned sale
Price
73.35
Quantity 5,707 -12.3%
Value US$418,614
3.2
Cole G Bradley CFO
Transaction date
Planned sale
Price
72.10
Quantity 17,531 -27.4%
Value US$1,264,066
Pla Frederic COO Officer
Transaction date
Planned sale
Price
75.00
Quantity 1,251 -3.8%
Value US$93,825
Radford Jason W. Chief Legal Officer Officer
Transaction date
Planned sale
Price
74.80
Quantity 100 -0.3%
Value US$7,480
Radford Jason W. Chief Legal Officer Officer
Transaction date
Planned sale
Price
74.09
Quantity 2,081 -6.6%
Value US$154,189
Popovits Kimberly J President and CEO Executive Director
Transaction date
Planned sale
Price
74.67
Quantity 5,091 -4.9%
Value US$380,162
Popovits Kimberly J President and CEO Executive Director
Transaction date
Planned sale
Price
73.72
Quantity 4,909 -4.5%
Value US$361,903
Popovits Kimberly J President and CEO Executive Director
Transaction date
Planned sale
Price
74.68
Quantity 7,607 -6.6%
Value US$568,092
Popovits Kimberly J President and CEO Executive Director
Transaction date
Planned sale
Price
73.72
Quantity 7,393 -6.0%
Value US$545,042
Popovits Kimberly J President and CEO Executive Director
Transaction date
Planned sale
Price
73.76
Quantity 447 -0.4%
Value US$32,970
Popovits Kimberly J President and CEO Executive Director
Transaction date
Planned sale
Price
73.30
Quantity 24,553 -18.4%
Value US$1,799,683
Cole G Bradley CFO Officer
Transaction date
Planned sale
Price
73.75
Quantity 1,225 -3.0%
Value US$90,346
Cole G Bradley CFO Officer
Transaction date
Planned sale
Price
73.30
Quantity 58,775 -59.4%
Value US$4,308,243
Popovits Kimberly J President and CEO Executive Director
Transaction date
Planned sale
Price
74.37
Quantity 1,000 -0.9%
Value US$74,369
Popovits Kimberly J President and CEO Executive Director
Transaction date
Planned sale
Price
73.63
Quantity 24,000 -18.0%
Value US$1,767,173
Popovits Kimberly J President and CEO Executive Director
Transaction date
Planned sale
Price
74.23
Quantity 9,235 -7.8%
Value US$685,470
Popovits Kimberly J President and CEO Executive Director
Transaction date
Planned sale
Price
73.63
Quantity 15,765 -11.8%
Value US$1,160,796
Vaughn James J Chief Commercial Officer Officer
Transaction date
Planned sale
Price
74.21
Quantity 1,277 -7.2%
Value US$94,770
Vaughn James J Chief Commercial Officer Officer
Transaction date
Planned sale
Price
73.56
Quantity 1,723 -8.9%
Value US$126,748
Vaughn James J Chief Commercial Officer Officer
Transaction date
Planned sale
Price
74.20
Quantity 403 -2.0%
Value US$29,903
Vaughn James J Chief Commercial Officer Officer
Transaction date
Planned sale
Price
73.57
Quantity 700 -3.4%
Value US$51,502
Vaughn James J Chief Commercial Officer Officer
Transaction date
Planned sale
Price
72.80
Quantity 397 -1.9%
Value US$28,902
Shak Steven Chief Scientific Officer Officer
Transaction date
Planned sale
Price
72.86
Quantity 8,140 -8.9%
Value US$593,088
Shak Steven Chief Scientific Officer Officer
Transaction date
Planned sale
Price
72.14
Quantity 16,860 -15.5%
Value US$1,216,243
McEachron Kim Chief People Officer Officer
Transaction date
Planned sale
Price
71.53
Quantity 12,103 -24.9%
Value US$865,723
Shak Steven Chief Scientific Officer Officer
Transaction date
Planned sale
Price
71.85
Quantity 2,471 -2.2%
Value US$177,544
Shak Steven Chief Scientific Officer Officer
Transaction date
Planned sale
Price
71.22
Quantity 22,529 -16.8%
Value US$1,604,585
Shak Steven Chief Scientific Officer Officer
Transaction date
Planned sale
Price
72.43
Quantity 25,000 -15.7%
Value US$1,810,858
Shak Steven Chief Scientific Officer Officer
Transaction date
Planned sale
Price
73.22
Quantity 7,372 -4.4%
Value US$539,807
Shak Steven Chief Scientific Officer Officer
Transaction date
Planned sale
Price
72.72
Quantity 17,628 -9.6%
Value US$1,281,977
3.2
Cole G Bradley CFO
Transaction date
Planned sale
Price
57.33
Quantity 5,033 -10.3%
Value US$288,527
3.2
Cole G Bradley CFO
Transaction date
Planned sale
Price
56.23
Quantity 1,438 -2.9%
Value US$80,859
Shak Steven Chief Scientific Officer
Transaction date
Planned sale
Price
57.06
Quantity 7,800 -4.1%
Value US$445,034
Shak Steven Chief Scientific Officer
Transaction date
Planned sale
Price
56.27
Quantity 17,200 -8.2%
Value US$967,909
Shak Steven Chief Scientific Officer
Transaction date
Planned sale
Price
57.76
Quantity 4,048 -1.9%
Value US$233,814
Shak Steven Chief Scientific Officer
Transaction date
Planned sale
Price
56.97
Quantity 20,952 -9.0%
Value US$1,193,570
Vaughn James J Chief Commercial Officer
Transaction date
Planned sale
Price
57.74
Quantity 200 -1.2%
Value US$11,548
Vaughn James J Chief Commercial Officer
Transaction date
Planned sale
Price
56.95
Quantity 1,300 -7.3%
Value US$74,030
Vaughn James J Chief Commercial Officer
Transaction date
Planned sale
Price
57.85
Quantity 501 -2.7%
Value US$28,985
Vaughn James J Chief Commercial Officer
Transaction date
Planned sale
Price
56.95
Quantity 2,499 -11.9%
Value US$142,324
McEachron Kim Chief People Officer
Transaction date
Planned sale
Price
60.01
Quantity 5,335 -12.8%
Value US$320,151
Shak Steven Chief Scientific Officer
Transaction date
Planned sale
Price
52.27
Quantity 1,664 -0.7%
Value US$86,982
Shak Steven Chief Scientific Officer
Transaction date
Planned sale
Price
51.54
Quantity 8,886 -3.6%
Value US$458,021
Shak Steven Chief Scientific Officer
Transaction date
Planned sale
Price
52.43
Quantity 809 -0.3%
Value US$42,416
Shak Steven Chief Scientific Officer
Transaction date
Planned sale
Price
51.93
Quantity 24,191 -9.3%
Value US$1,256,156
Shak Steven Chief Scientific Officer
Transaction date
Planned sale
Price
51.34
Quantity 25,000 -9.7%
Value US$1,283,478
3.2
Cole G Bradley CFO
Transaction date
Planned sale
Price
52.34
Quantity 770 -1.7%
Value US$40,303
3.2
Cole G Bradley CFO
Transaction date
Planned sale
Price
51.30
Quantity 4,230 -8.7%
Value US$216,979
Shak Steven Chief Scientific Officer
Transaction date
Planned sale
Price
52.33
Quantity 3,702 -1.6%
Value US$193,730
Shak Steven Chief Scientific Officer
Transaction date
Planned sale
Price
51.27
Quantity 21,298 -8.2%
Value US$1,091,972
Vaughn James J Chief Commercial Officer
Transaction date
Planned sale
Price
54.65
Quantity 271 -1.6%
Value US$14,810
Vaughn James J Chief Commercial Officer
Transaction date
Planned sale
Price
53.06
Quantity 370 -2.2%
Value US$19,631
Vaughn James J Chief Commercial Officer
Transaction date
Planned sale
Price
52.25
Quantity 3,604 -17.6%
Value US$188,318
Vaughn James J Chief Commercial Officer
Transaction date
Planned sale
Price
54.65
Quantity 100 -0.5%
Value US$5,465
Vaughn James J Chief Commercial Officer
Transaction date
Planned sale
Price
52.30
Quantity 1,400 -6.4%
Value US$73,217
Vaughn James J Chief Commercial Officer
Transaction date
Planned sale
Price
54.70
Quantity 200 -0.9%
Value US$10,940
Vaughn James J Chief Commercial Officer
Transaction date
Planned sale
Price
53.04
Quantity 200 -0.9%
Value US$10,607
Vaughn James J Chief Commercial Officer
Transaction date
Planned sale
Price
52.25
Quantity 2,600 -10.4%
Value US$135,841
3.2
Cole G Bradley CFO Officer
Transaction date
Planned sale
Price
57.36
Quantity 4,674 -9.7%
Value US$268,103
3.2
Cole G Bradley CFO Officer
Transaction date
Planned sale
Price
56.66
Quantity 1,750 -3.5%
Value US$99,164
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2019-11-13 2019-11-08 B Purchase EXACT SCIENCES CORP

See Footnotes

Large shareholder
38,057
201.04
US$1,334,501 		38,057 201.04 US$1,334,501
2019-10-21 2019-10-17 PlS Planned sale
Leber Laura

Chief Communication Officer
77,934 +27.2%
464.43
US$3,832,758 		77,934 +27.2% 464.43 US$3,832,758
2019-10-09 2019-10-08 PlS Planned sale
Vaughn James J

Chief Commercial Officer
51,285 -28.3%
89.05
US$4,901,790 		51,285 -28.3% 89.05 US$4,901,790
2019-10-09 2019-10-08 PlS Planned sale
Popovits Kimberly J

President and CEO

Executive Director
10,000 -12.8%
67.74
US$677,364 		10,000 -12.8% 67.74 US$677,364
2019-10-09 2019-10-07 PlS Planned sale
3.2
Cole G Bradley

CFO
22,560 -36.7%
69.01
US$1,556,886 		22,560 -36.7% 69.01 US$1,556,886
2019-09-19 2019-09-17 PlS Planned sale
Shak Steven

Chief Scientific Officer
25,000 -29.8%
71.47
US$1,786,692 		25,000 -29.8% 71.47 US$1,786,692
2019-09-11 2019-09-10 PlS Planned sale
3.2
Cole G Bradley

CFO
4,809 -11.0%
72.33
US$347,848 		4,809 -11.0% 72.33 US$347,848
2019-09-11 2019-09-10 PlS Planned sale
3.2
Cole G Bradley

CFO
13,303 -23.3%
71.60
US$952,428 		13,303 -23.3% 71.60 US$952,428
2019-09-11 2019-09-09 PlS Planned sale
Vaughn James J

Chief Commercial Officer
200 -1.2%
74.13
US$14,826 		200 -1.2% 74.13 US$14,826
2019-09-11 2019-09-09 PlS Planned sale
Vaughn James J

Chief Commercial Officer
1,300 -7.3%
73.24
US$95,213 		1,300 -7.3% 73.24 US$95,213
2019-09-11 2019-09-09 PlS Planned sale
Vaughn James J

Chief Commercial Officer
3,000 -14.3%
72.08
US$216,230 		3,000 -14.3% 72.08 US$216,230
2019-09-11 2019-09-09 PlS Planned sale
Popovits Kimberly J

President and CEO

Executive Director
600 -0.8%
74.10
US$44,460 		600 -0.8% 74.10 US$44,460
2019-09-11 2019-09-09 PlS Planned sale
Popovits Kimberly J

President and CEO

Executive Director
2,483 -3.1%
73.35
US$182,125 		2,483 -3.1% 73.35 US$182,125
2019-09-11 2019-09-09 PlS Planned sale
Popovits Kimberly J

President and CEO

Executive Director
6,917 -7.8%
72.10
US$498,700 		6,917 -7.8% 72.10 US$498,700
2019-09-11 2019-09-09 PlS Planned sale
3.2
Cole G Bradley

CFO
1,762 -4.3%
74.00
US$130,392 		1,762 -4.3% 74.00 US$130,392
2019-09-11 2019-09-09 PlS Planned sale
3.2
Cole G Bradley

CFO
5,707 -12.3%
73.35
US$418,614 		5,707 -12.3% 73.35 US$418,614
2019-09-11 2019-09-09 PlS Planned sale
3.2
Cole G Bradley

CFO
17,531 -27.4%
72.10
US$1,264,066 		17,531 -27.4% 72.10 US$1,264,066
2019-08-21 2019-08-19 PlS Planned sale Pla Frederic

COO

Officer
1,251 -3.8%
75.00
US$93,825 		1,251 -3.8% 75.00 US$93,825
2019-08-19 2019-08-15 PlS Planned sale Radford Jason W.

Chief Legal Officer

Officer
100 -0.3%
74.80
US$7,480 		100 -0.3% 74.80 US$7,480
2019-08-19 2019-08-15 PlS Planned sale Radford Jason W.

Chief Legal Officer

Officer
2,081 -6.6%
74.09
US$154,189 		2,081 -6.6% 74.09 US$154,189
2019-08-14 2019-08-13 PlS Planned sale Popovits Kimberly J

President and CEO

Executive Director
5,091 -4.9%
74.67
US$380,162 		5,091 -4.9% 74.67 US$380,162
2019-08-14 2019-08-13 PlS Planned sale Popovits Kimberly J

President and CEO

Executive Director
4,909 -4.5%
73.72
US$361,903 		4,909 -4.5% 73.72 US$361,903
2019-08-14 2019-08-13 PlS Planned sale Popovits Kimberly J

President and CEO

Executive Director
7,607 -6.6%
74.68
US$568,092 		7,607 -6.6% 74.68 US$568,092
2019-08-14 2019-08-13 PlS Planned sale Popovits Kimberly J

President and CEO

Executive Director
7,393 -6.0%
73.72
US$545,042 		7,393 -6.0% 73.72 US$545,042
2019-08-14 2019-08-12 PlS Planned sale Popovits Kimberly J

President and CEO

Executive Director
447 -0.4%
73.76
US$32,970 		447 -0.4% 73.76 US$32,970
2019-08-14 2019-08-12 PlS Planned sale Popovits Kimberly J

President and CEO

Executive Director
24,553 -18.4%
73.30
US$1,799,683 		24,553 -18.4% 73.30 US$1,799,683
2019-08-14 2019-08-12 PlS Planned sale Cole G Bradley

CFO

Officer
1,225 -3.0%
73.75
US$90,346 		1,225 -3.0% 73.75 US$90,346
2019-08-14 2019-08-12 PlS Planned sale Cole G Bradley

CFO

Officer
58,775 -59.4%
73.30
US$4,308,243 		58,775 -59.4% 73.30 US$4,308,243
2019-08-12 2019-08-09 PlS Planned sale Popovits Kimberly J

President and CEO

Executive Director
1,000 -0.9%
74.37
US$74,369 		1,000 -0.9% 74.37 US$74,369
2019-08-12 2019-08-09 PlS Planned sale Popovits Kimberly J

President and CEO

Executive Director
24,000 -18.0%
73.63
US$1,767,173 		24,000 -18.0% 73.63 US$1,767,173
2019-08-12 2019-08-08 PlS Planned sale Popovits Kimberly J

President and CEO

Executive Director
9,235 -7.8%
74.23
US$685,470 		9,235 -7.8% 74.23 US$685,470
2019-08-12 2019-08-08 PlS Planned sale Popovits Kimberly J

President and CEO

Executive Director
15,765 -11.8%
73.63
US$1,160,796 		15,765 -11.8% 73.63 US$1,160,796
2019-08-12 2019-08-08 PlS Planned sale Vaughn James J

Chief Commercial Officer

Officer
1,277 -7.2%
74.21
US$94,770 		1,277 -7.2% 74.21 US$94,770
2019-08-12 2019-08-08 PlS Planned sale Vaughn James J

Chief Commercial Officer

Officer
1,723 -8.9%
73.56
US$126,748 		1,723 -8.9% 73.56 US$126,748
2019-08-12 2019-08-08 PlS Planned sale Vaughn James J

Chief Commercial Officer

Officer
403 -2.0%
74.20
US$29,903 		403 -2.0% 74.20 US$29,903
2019-08-12 2019-08-08 PlS Planned sale Vaughn James J

Chief Commercial Officer

Officer
700 -3.4%
73.57
US$51,502 		700 -3.4% 73.57 US$51,502
2019-08-12 2019-08-08 PlS Planned sale Vaughn James J

Chief Commercial Officer

Officer
397 -1.9%
72.80
US$28,902 		397 -1.9% 72.80 US$28,902
2019-08-07 2019-08-06 PlS Planned sale Shak Steven

Chief Scientific Officer

Officer
8,140 -8.9%
72.86
US$593,088 		8,140 -8.9% 72.86 US$593,088
2019-08-07 2019-08-06 PlS Planned sale Shak Steven

Chief Scientific Officer

Officer
16,860 -15.5%
72.14
US$1,216,243 		16,860 -15.5% 72.14 US$1,216,243
2019-08-07 2019-08-05 PlS Planned sale McEachron Kim

Chief People Officer

Officer
12,103 -24.9%
71.53
US$865,723 		12,103 -24.9% 71.53 US$865,723
2019-08-07 2019-08-05 PlS Planned sale Shak Steven

Chief Scientific Officer

Officer
2,471 -2.2%
71.85
US$177,544 		2,471 -2.2% 71.85 US$177,544
2019-08-07 2019-08-05 PlS Planned sale Shak Steven

Chief Scientific Officer

Officer
22,529 -16.8%
71.22
US$1,604,585 		22,529 -16.8% 71.22 US$1,604,585
2019-08-05 2019-08-02 PlS Planned sale Shak Steven

Chief Scientific Officer

Officer
25,000 -15.7%
72.43
US$1,810,858 		25,000 -15.7% 72.43 US$1,810,858
2019-08-05 2019-08-01 PlS Planned sale Shak Steven

Chief Scientific Officer

Officer
7,372 -4.4%
73.22
US$539,807 		7,372 -4.4% 73.22 US$539,807
2019-08-05 2019-08-01 PlS Planned sale Shak Steven

Chief Scientific Officer

Officer
17,628 -9.6%
72.72
US$1,281,977 		17,628 -9.6% 72.72 US$1,281,977
2019-07-11 2019-07-09 PlS Planned sale
3.2
Cole G Bradley

CFO
5,033 -10.3%
57.33
US$288,527 		5,033 -10.3% 57.33 US$288,527
2019-07-11 2019-07-09 PlS Planned sale
3.2
Cole G Bradley

CFO
1,438 -2.9%
56.23
US$80,859 		1,438 -2.9% 56.23 US$80,859
2019-07-10 2019-07-09 PlS Planned sale
Shak Steven

Chief Scientific Officer
7,800 -4.1%
57.06
US$445,034 		7,800 -4.1% 57.06 US$445,034
2019-07-10 2019-07-09 PlS Planned sale
Shak Steven

Chief Scientific Officer
17,200 -8.2%
56.27
US$967,909 		17,200 -8.2% 56.27 US$967,909
2019-07-10 2019-07-08 PlS Planned sale
Shak Steven

Chief Scientific Officer
4,048 -1.9%
57.76
US$233,814 		4,048 -1.9% 57.76 US$233,814
2019-07-10 2019-07-08 PlS Planned sale
Shak Steven

Chief Scientific Officer
20,952 -9.0%
56.97
US$1,193,570 		20,952 -9.0% 56.97 US$1,193,570
2019-07-09 2019-07-08 PlS Planned sale
Vaughn James J

Chief Commercial Officer
200 -1.2%
57.74
US$11,548 		200 -1.2% 57.74 US$11,548
2019-07-09 2019-07-08 PlS Planned sale
Vaughn James J

Chief Commercial Officer
1,300 -7.3%
56.95
US$74,030 		1,300 -7.3% 56.95 US$74,030
2019-07-09 2019-07-08 PlS Planned sale
Vaughn James J

Chief Commercial Officer
501 -2.7%
57.85
US$28,985 		501 -2.7% 57.85 US$28,985
2019-07-09 2019-07-08 PlS Planned sale
Vaughn James J

Chief Commercial Officer
2,499 -11.9%
56.95
US$142,324 		2,499 -11.9% 56.95 US$142,324
2019-07-09 2019-07-05 PlS Planned sale
McEachron Kim

Chief People Officer
5,335 -12.8%
60.01
US$320,151 		5,335 -12.8% 60.01 US$320,151
2019-06-17 2019-06-14 PlS Planned sale
Shak Steven

Chief Scientific Officer
1,664 -0.7%
52.27
US$86,982 		1,664 -0.7% 52.27 US$86,982
2019-06-17 2019-06-14 PlS Planned sale
Shak Steven

Chief Scientific Officer
8,886 -3.6%
51.54
US$458,021 		8,886 -3.6% 51.54 US$458,021
2019-06-17 2019-06-13 PlS Planned sale
Shak Steven

Chief Scientific Officer
809 -0.3%
52.43
US$42,416 		809 -0.3% 52.43 US$42,416
2019-06-17 2019-06-13 PlS Planned sale
Shak Steven

Chief Scientific Officer
24,191 -9.3%
51.93
US$1,256,156 		24,191 -9.3% 51.93 US$1,256,156
2019-06-13 2019-06-12 PlS Planned sale
Shak Steven

Chief Scientific Officer
25,000 -9.7%
51.34
US$1,283,478 		25,000 -9.7% 51.34 US$1,283,478
2019-06-13 2019-06-11 PlS Planned sale
3.2
Cole G Bradley

CFO
770 -1.7%
52.34
US$40,303 		770 -1.7% 52.34 US$40,303
2019-06-13 2019-06-11 PlS Planned sale
3.2
Cole G Bradley

CFO
4,230 -8.7%
51.30
US$216,979 		4,230 -8.7% 51.30 US$216,979
2019-06-13 2019-06-11 PlS Planned sale
Shak Steven

Chief Scientific Officer
3,702 -1.6%
52.33
US$193,730 		3,702 -1.6% 52.33 US$193,730
2019-06-13 2019-06-11 PlS Planned sale
Shak Steven

Chief Scientific Officer
21,298 -8.2%
51.27
US$1,091,972 		21,298 -8.2% 51.27 US$1,091,972
2019-06-10 2019-06-06 PlS Planned sale
Vaughn James J

Chief Commercial Officer
271 -1.6%
54.65
US$14,810 		271 -1.6% 54.65 US$14,810
2019-06-10 2019-06-06 PlS Planned sale
Vaughn James J

Chief Commercial Officer
370 -2.2%
53.06
US$19,631 		370 -2.2% 53.06 US$19,631
2019-06-10 2019-06-06 PlS Planned sale
Vaughn James J

Chief Commercial Officer
3,604 -17.6%
52.25
US$188,318 		3,604 -17.6% 52.25 US$188,318
2019-06-10 2019-06-06 PlS Planned sale
Vaughn James J

Chief Commercial Officer
100 -0.5%
54.65
US$5,465 		100 -0.5% 54.65 US$5,465
2019-06-10 2019-06-06 PlS Planned sale
Vaughn James J

Chief Commercial Officer
1,400 -6.4%
52.30
US$73,217 		1,400 -6.4% 52.30 US$73,217
2019-06-10 2019-06-06 PlS Planned sale
Vaughn James J

Chief Commercial Officer
200 -0.9%
54.70
US$10,940 		200 -0.9% 54.70 US$10,940
2019-06-10 2019-06-06 PlS Planned sale
Vaughn James J

Chief Commercial Officer
200 -0.9%
53.04
US$10,607 		200 -0.9% 53.04 US$10,607
2019-06-10 2019-06-06 PlS Planned sale
Vaughn James J

Chief Commercial Officer
2,600 -10.4%
52.25
US$135,841 		2,600 -10.4% 52.25 US$135,841
2019-05-15 2019-05-14 PlS Planned sale
3.2
Cole G Bradley

CFO

Officer
4,674 -9.7%
57.36
US$268,103 		4,674 -9.7% 57.36 US$268,103
2019-05-15 2019-05-14 PlS Planned sale
3.2
Cole G Bradley

CFO

Officer
1,750 -3.5%
56.66
US$99,164 		1,750 -3.5% 56.66 US$99,164
Explore more

More insider trading research around Genomic Health Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America